Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial

  • Tapan M. Kadia
  • , Patrick K. Reville
  • , Gautam Borthakur
  • , Musa Yilmaz
  • , Steven Kornblau
  • , Yesid Alvarado
  • , Courtney D. Dinardo
  • , Naval Daver
  • , Nitin Jain
  • , Naveen Pemmaraju
  • , Nicholas Short
  • , Sa A. Wang
  • , Rebecca S.S. Tidwell
  • , Rabiul Islam
  • , Marina Konopleva
  • , Guillermo Garcia-Manero
  • , Farhad Ravandi
  • , Hagop M. Kantarjian

Research output: Contribution to journal › Article › peer-review

170 Scopus citations

Fingerprint

Dive into the research topics of 'Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science